2006
DOI: 10.1253/circj.70.977
|View full text |Cite
|
Sign up to set email alerts
|

Amiodarone Therapy in Patients Implanted With Cardioverter-Defibrillator for Life-Threatening Ventricular Arrhythmias

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 26 publications
0
16
0
Order By: Relevance
“…Therefore, the development of a ICD algorithm that monitors the magnitude of TWA might be warranted for detecting the high-risk condition of VT/VF and to evaluate the effects of antiarrhythmic drugs in patients with ICD storm. [38][39][40] …”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the development of a ICD algorithm that monitors the magnitude of TWA might be warranted for detecting the high-risk condition of VT/VF and to evaluate the effects of antiarrhythmic drugs in patients with ICD storm. [38][39][40] …”
Section: Discussionmentioning
confidence: 99%
“…5 The screening may also prevent living family members from suffering possible sudden death by appropriate medication or lifestyle changes. [25][26][27][28][29] We have also discussed the possibility that the RyR2 mutation may be associated with status thymicolymphaticus.…”
Section: Discussionmentioning
confidence: 99%
“…13 The efficacy of amiodarone for reducing inappropriate ICD therapies in patients with structural heart disease has been reported previously 14 and more recently, it was reported that amiodarone is effective for preventing inappropriate ICD therapies in selected patients with atrial fibrillation (AF). 15 However, the exact background to the reduction in inappropriate therapies provided by amiodarone has still not been fully investigated.…”
Section: Editorial P 1290mentioning
confidence: 92%
“…The OPTIC trial suggested that amiodarone and β-antagonists could prevent inappropriate ICD therapy and our study has emphasized that result. However, β-blocker use was only 44% in a large cohort study in Japan, 21 indicating it is not frequently administered in the Japanese patient population with structural heart disease and ICD implantation. We could not confirm the reason for the relatively lower use of β-blockers in our study.…”
Section: Study Limitationsmentioning
confidence: 99%